Homepage

Epidemiology

Examine the prevalence of lung cancer among veterans and the general population, the high mortality risk, histological differences between small cell and non-small cell lung cancer, and common causes of the disease.

LEARN MORE >

Screening and diagnosis

Explore NCCN Guidelines® for lung cancer screening in select high-risk patients, the benefits of early screening with low-dose CT, and prognosis by stage of disease.

LEARN MORE >

NSCLC histology

Learn about subtypes of NSCLC, the prognostic impact of squamous histology, and the role histological and molecular biomarkers play in treatment selection.

LEARN MORE >

Treatment

Investigate lung cancer staging and its impact on treatment, systemic therapeutic options and FDA-approved treatments for advanced NSCLC, meaningful clinical end points, and treatment patterns both inside the VA and in the broader patient population.

LEARN MORE >

VA considerations

Assess the relevance of lung cancer to a growing elderly population, the challenges associated with eldercare, and the importance of emotional care—particularly among veterans, who have a higher rate of significant depressive symptoms than the general population.

LEARN MORE >

Resources

Utilize resources designed to help patients and caregivers understand, manage, and cope
with a diagnosis of lung cancer.

LEARN MORE >

Back to top
click me